Printer Friendly
The Free Library
14,815,112 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AmerisourceBergen to Purchase All Branded and Generic Pharmaceuticals Only from Manufacturers.


VALLEY FORGE Valley Forge, on the Schuylkill River, SE Pa., NW of Philadelphia. There, during the American Revolution, the main camp of the Continental Army was established (Dec., 1777–June, 1778) under the command of Gen. George Washington. , Pa. -- AmerisourceBergen Corporation (NYSE NYSE

See: New York Stock Exchange
:ABC ABC
 in full American Broadcasting Co.

Major U.S. television network. It began when the expanding national radio network NBC split into the separate Red and Blue networks in 1928.
), one of the largest pharmaceutical services companies in the nation, today announced that effective October 1, 2005, it will purchase all of its branded and generic pharmaceuticals for distribution in the U.S. only from manufacturers. In the rare instances in which a manufacturer requires the Company to purchase products from an exclusive distributor, AmerisourceBergen will follow the manufacturer's requirements. This change is not expected to have a material impact on the Company's fiscal year 2006 earnings.

Currently AmerisourceBergen purchases more than 99.5 percent of its pharmaceuticals directly from manufacturers. The Company purchases the remainder, less than one half of one percent, only from authorized au·thor·ize  
tr.v. au·thor·ized, au·thor·iz·ing, au·thor·iz·es
1. To grant authority or power to.

2. To give permission for; sanction:
 distributors of the manufacturer.

"While our stringent requirements keep our supply chain secure today, we are taking this added step to further assure our provider customers of the safety of the product we sell to them," said Kurt J. Hilzinger, AmerisourceBergen President and Chief Operating Officer Chief Operating Officer (COO)

The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president.
. "This important action will help strengthen the integrity of the U.S. pharmaceutical supply channel."

About AmerisourceBergen

AmerisourceBergen (NYSE:ABC) is one of the largest pharmaceutical services companies in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen's service solutions range from pharmacy automation and pharmaceutical packaging to pharmacy services for skilled nursing and assisted living as·sist·ed living
n.
A living arrangement in which people with special needs, especially older people with disabilities, reside in a facility that provides help with everyday tasks such as bathing, dressing, and taking medication.
 facilities, reimbursement Reimbursement

Payment made to someone for out-of-pocket expenses has incurred.
 and pharmaceutical consulting services Noun 1. consulting service - service provided by a professional advisor (e.g., a lawyer or doctor or CPA etc.)
service - work done by one person or group that benefits another; "budget separately for goods and services"
, and physician education. With more than $54 billion in revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs more than 14,000 people. AmerisourceBergen is ranked #23 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.

FORWARD-LOOKING STATEMENTS forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 

This news release may contain certain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may vary materially from the expectations contained in the forward-looking statements. Forward-looking statements may include statements addressing AmerisourceBergen's future financial and operating results and the benefits, efficiencies and savings to be derived from the Company's integration plans to consolidate its distribution network.

The following factors, among others, could cause actual results to differ materially from those described in any forward-looking statements: competitive pressures; the loss of one or more key customer or supplier relationships; customer defaults or insolvencies; changes in customer mix; supplier defaults or insolvencies; changes in pharmaceutical manufacturers' pricing and distribution policies or practices; adverse resolution of any contract or other disputes with customers (including departments and agencies of the U.S. Government) or suppliers; regulatory changes; changes in U.S. government policies (including reimbursement changes arising from the Medicare Modernization modernization

Transformation of a society from a rural and agrarian condition to a secular, urban, and industrial one. It is closely linked with industrialization. As societies modernize, the individual becomes increasingly important, gradually replacing the family,
 Act); market interest rates; operational or control issues arising from AmerisourceBergen's outsourcing of information technology activities; success of the Pharmaceutical Distribution segment's ability to transition its business model to fee-for-service; success of integration, restructuring or systems initiatives; acquisition of businesses that do not perform as we expect or that are difficult for us to integrate or control; and other economic, business, competitive, legal, regulatory and/or operational factors affecting the business of AmerisourceBergen generally.

More detailed information about these and other risk factors is set forth in AmerisourceBergen's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for fiscal 2004.

AmerisourceBergen is under no obligation to (and expressly disclaims any such obligation to) update or alter any forward -looking statements whether as a result of new information, future events or otherwise.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Sep 22, 2005
Words:605
Previous Article:SEBIO Announces William Haseltine, Ph.D., and Arthur Klausner Will Be Luncheon Seakers at Its Annual Biotechnology Investor Forum; Founder of Human...
Next Article:Port City Java(R) Opens 4 Cafes in Existing Markets.
Topics:



Related Articles
AmerisourceBergen Signs Agreement to Purchase US Bioservices Corporation; Largest Pharmaceutical Distributor Adds Specialty Pharmaceutical Services...
AmerisourceBergen Signs Agreement to Purchase Anderson Packaging, Inc.; Largest Pharmaceutical Distributor Adds Contract Pharmaceutical Packaging...
AmerisourceBergen Completes Acquisition of Anderson Packaging, Inc.
AmerisourceBergen Expects Diluted EPS from Continuing Operations of $4.00 to $4.10 for FY 2005 and $0.60 to $0.65 for the December Quarter.
AmerisourceBergen Confirms Diluted EPS From Continuing Operations of $4.00 to $4.10 for FY 2005 and $0.60 to $0.65 for the December Quarter.
AmerisourceBergen Expects Diluted EPS from Continuing Operations of $3.10 to $3.50 for FY 2005 and $0.75 to $0.85 for the March Quarter.
PharMerica Settles OIG Notice of Action; Company Pays Approximately $6 Million as Part of Settlement.
AmerisourceBergen Announces Accelerated Share Repurchase Transaction.
AmerisourceBergen to Acquire Oncology Service Provider, NMCR, LLC.; AmerisourceBergen Adds Accredited Physician Education and Analytical Research to...
AmerisourceBergen to Acquire Bellco Health.

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles